These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 19278396

  • 1. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
    Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE.
    J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
    [Abstract] [Full Text] [Related]

  • 2. Association between apolipoprotein E4 and cognitive decline in elderly adults.
    Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C, Prospective Study of Pravastatin in the Elderly at Risk Group.
    J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899
    [Abstract] [Full Text] [Related]

  • 3. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 4. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Jun; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.
    Dement Geriatr Cogn Disord; 2007 Jun; 23(5):327-33. PubMed ID: 17374951
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [Abstract] [Full Text] [Related]

  • 7. Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.
    Pomara N, Belzer K, Hernando R, De La Pena C, Sidtis JJ.
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):116-24. PubMed ID: 18239197
    [Abstract] [Full Text] [Related]

  • 8. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype.
    Kanaya K, Abe S, Sakai M, Fujii H, Iwamoto T.
    Geriatr Gerontol Int; 2010 Jan; 10(1):25-31. PubMed ID: 20102379
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the diagnostic accuracy of the Cognitive Performance Scale (Minimum Data Set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents.
    Paquay L, De Lepeleire J, Schoenmakers B, Ylieff M, Fontaine O, Buntinx F.
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):286-93. PubMed ID: 17022109
    [Abstract] [Full Text] [Related]

  • 10. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians.
    Bathum L, Christiansen L, Jeune B, Vaupel J, McGue M, Christensen K.
    J Am Geriatr Soc; 2006 Apr; 54(4):654-8. PubMed ID: 16686878
    [Abstract] [Full Text] [Related]

  • 12. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E epsilon4 and anticholinergic cognitive toxicity.
    Pomara N, Sidtis J.
    J Am Geriatr Soc; 2009 Nov; 57(11):2151. PubMed ID: 20121960
    [No Abstract] [Full Text] [Related]

  • 14. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study.
    Avila-Funes JA, Amieva H, Barberger-Gateau P, Le Goff M, Raoux N, Ritchie K, Carrière I, Tavernier B, Tzourio C, Gutiérrez-Robledo LM, Dartigues JF.
    J Am Geriatr Soc; 2009 Mar; 57(3):453-61. PubMed ID: 19245415
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, Moss M, Albert M.
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [Abstract] [Full Text] [Related]

  • 16. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P, Oleksik AM, Mooijaart SP, de Craen AJ, Westendorp RG.
    Neurology; 2009 Mar 03; 72(9):821-8. PubMed ID: 19255409
    [Abstract] [Full Text] [Related]

  • 17. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.
    J Clin Psychiatry; 2009 Oct 03; 70(10):1379-84. PubMed ID: 19573495
    [Abstract] [Full Text] [Related]

  • 18. The effect of the ApoE genotype on the association between head circumference and cognition.
    Kim KR, Lee KS, Kim EA, Cheong HK, Oh BH, Hong CH.
    Am J Geriatr Psychiatry; 2008 Oct 03; 16(10):819-25. PubMed ID: 18827228
    [Abstract] [Full Text] [Related]

  • 19. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
    Konishi K, Hori K, Uchida H, Watanabe K, Tominaga I, Kimura M, Hosoyamada M, Shibasaki T, Kataoka A, Hachisu M.
    Psychogeriatrics; 2010 Mar 03; 10(1):34-8. PubMed ID: 20594285
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N, Willoughby L, Wesnes K, Greenblatt DJ, Sidtis JJ.
    Arch Gen Psychiatry; 2005 Feb 03; 62(2):209-16. PubMed ID: 15699298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.